Federal Register: February 17, 2009 (Volume 74, Number 30)
DOCID: fr17fe09-104 FR Doc E9-3193
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
NOTICE: NOTICES
DOCID: fr17fe09-104
ACTION: Meetings:
SUBJECT CATEGORY:
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
DOCUMENT SUMMARY:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, Innate Immune Receptors & Adjuvant Discovery.
Date: March 1617, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: Crowne Plaza HotelSilver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910.
Contact Person: Paul A. Amstad, PhD, Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC
7616, Bethesda, MD 208927616, 3014962550, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
Dated: February 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E93193 Filed 21309; 8:45 am]
BILLING CODE 414001P
SUMMARY:
National Institute of Allergy and Infectious Diseases,
DOCUMENT BODY 2:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, Innate Immune Receptors & Adjuvant Discovery.
Date: March 1617, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: Crowne Plaza HotelSilver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910.
Contact Person: Paul A. Amstad, PhD, Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC
7616, Bethesda, MD 208927616, 3014962550, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
Dated: February 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E93193 Filed 21309; 8:45 am]
BILLING CODE 414001P